机器人对比腹腔镜分期用于早期卵巢癌:病例匹配对照研究
本研究为回顾性队列研究,纳入96例疑似I期卵巢癌接受微创分期的患者,其中32例机器人分期、64例腹腔镜分期。两组在分期、组织学、分级、淋巴结切除数、出血量和并发症方面无显著差异,机器人组手术时间显著更短。作者认为两种方法在早期卵巢癌分期中无相关差异,需进一步前瞻性试验确认。
要点
- 机器人组与腹腔镜组在最终FIGO分期、组织学、分级上无统计学显著差异。
- 机器人组手术时间显著短于腹腔镜组(p=.043),估计出血量相似(p=.691)。
- 两组盆腔及主动脉淋巴结切除数、早期和术后并发症均无显著差异。
核心结论
- 本研究提示机器人分期与腹腔镜分期在早期卵巢癌中无相关差异。
- 需进一步前瞻性试验确认本研究结果。
研究设计与样本
- 回顾性队列研究(加拿大任务组分类II-2)。
- 研究地点为意大利罗马圣心天主教大学。
- 共96例疑似I期卵巢癌患者接受微创分期,其中32例机器人组(病例)、64例腹腔镜组(对照)。
主要发现
- 全组15例(15.6%)发生分期上调,两组间无统计学显著差异。
- 机器人组与腹腔镜组盆腔淋巴结切除中位数分别为14枚(范围3-42)与11枚(范围2-29)(p=.235)。
- 机器人组与腹腔镜组主动脉淋巴结切除中位数分别为11枚(范围3-26)与12枚(范围1-39)(p=.263)。
- 机器人组手术时间显著短于腹腔镜组(p=.043),估计出血量两组相似(p=.691)。
- 两组早期和术后并发症无差异;共72例被认为需要辅助治疗,2例出现腹膜复发。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
- 作者指出需进一步前瞻性试验确认本研究结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To evaluate the feasibility, surgical outcome, and oncologic results observed after robotic staging compared with conventional laparoscopic staging for patients with early-stage ovarian cancer patients. DESIGN: A retrospective cohort study (Canadian Task Force classification II-2). SETTING: Catholic University of the Sacred Heart, Rome, Italy. PATIENTS: Ninety-six patients underwent minimally invasive staging for presumed stage I ovarian cancer; 32 underwent the robotic approach (cases), and 64 underwent the laparoscopic approach (controls). MEASUREMENTS AND MAIN RESULTS: There was no statistically significant difference between the 2 approaches with regard to final Fédération Internationale de Gynécologie et d'Obstétrique stage, histology, and grade of tumors. In the whole series, 15 patients (15.6%) were upstaged, with no statistically significant difference between the 2 groups. The median number of pelvic lymph nodes removed was 14 (range, 3-42) and 11 (range, 2-29) in the robotic and laparoscopic groups (p = .235), respectively. The median number of aortic lymph nodes removed was 11 (range, 3-26) and 12 (range, 1-39) in the robotic and laparoscopic groups (p = .263), respectively. The operative time was significantly shorter in the robotic group compared with the laparoscopic group (p = .043), whereas the amount of estimated blood loss was similar (p = .691). No difference was found in terms of early and postoperative complications. Overall, 72 patients were considered as requiring adjuvant treatment. Two patients experienced peritoneal recurrence. CONCLUSION: The present study suggests that there is no relevant difference between the robotic and laparoscopic approaches in staging early-stage ovarian cancer. Further prospective trials are needed to confirm our results.
引用
- Gallotta V, Cicero C, Conte C, et al. Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study. J Minim Invasive Gynecol. 2016. PMID: 27856387. doi:10.1016/j.jmig.2016.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。